Skip to main content

Table 1 Demographics, birth statistics, and health insurance status

From: Retrospective analysis of the diagnostic yield of newborn drug testing

 

Results of meconium testing

 

Group A

Group B

Group C

Group D

 

No drug(s) or metabolite(s) detected1(n = 1,916)

All findings explained by prescribed medication(s) (n = 283)

Non-medical drug use detected2(n = 229)

Unexplained drug(s) or metabolite(s) detected (n = 69)

Maternal age (years) 3

26 (10)

27 (9)

26 (7)

26 (8)

Gestational age (weeks) 3

38 (5.2)

35.9 (7.6)

38 (5.3)

36.7 (7)

Gravida 3

2 (3)

2 (2)

3 (3)

3 (2)

Para 3

1 (2)

1 (1)

2 (2)

2 (2)

Days meconium collected after birth 3

0 (1)

1 (6)

0 (1)

1 (2)

Health insurance Status

    

Private insurance

31.0%

30.7%

12.7%

31.9%

Student insurance

1.0%

0.7%

0.0%

0.0%

Medicaid

47.5%

42.4%

63.3%

47.8%

Uninsured

20.0%

25.8%

24.0%

20.3%

Self-Declared Race

    

Caucasian

77.0%

72.4%

61.6%

75.4%

African-American

9.0%

9.5%

27.9%

10.1%

Hispanic

9.0%

6.0%

1.3%

5.8%

Native American

1.0%

1.8%

0.9%

0.0%

Mixed race

0.5%

1.4%

3.9%

2.9%

Asian/Pacific Islander

1.5%

1.4%

0.0%

0.0%

Unknown race

2.0%

7.4%

4.4%

5.8%

  1. 1Random sample of 200 within the total group of 1,916 was reviewed in detail and used for frequency calculations.
  2. 2Non-medical drug use includes amphetamines (amphetamine, methamphetamine, Ecstasy), benzodiazepines, cannabis, cocaine, and opioids used outside of health professional outpatient prescription or inpatient administration.
  3. 3Data for these variables are presented as median (interquartile range). Gravida is the number of times a woman has been pregnant. Para is the number of pregnancies carried to viable gestational age.